CVE-2026-67612 openemr CVE debrief

Who should care

Defenders responsible for OpenEMR deployments, particularly those using the patient portal template system, should assess exposure and prioritize verification and remediation efforts.

Why it matters

CVE-2026-67612 is a stored cross-site scripting vulnerability in OpenEMR patient portal template system that allows authenticated administrators to inject malicious payloads. Defenders should prioritize verifying and updating OpenEMR template systems, ensuring proper output encoding, and configuring HttpOnly cookie attributes to prevent session token exfiltration. The vulnerability requires verification of affected versions and remediation steps from official sources.

• Session token exfiltration and hijacking
• Arbitrary HTML and JavaScript injection
• Lateral movement through poisoned templates

Technical summary

The OpenEMR patient portal template system contains a stored cross-site scripting vulnerability that allows authenticated administrators to inject arbitrary HTML and JavaScript. The vulnerability exists due to lack of output encoding at template retrieval endpoint and missing HttpOnly cookie attributes. Attackers can exploit this vulnerability to exfiltrate session tokens via document.cookie access, enabling full session hijacking of any admin, clinician, or portal patient who views a poisoned template.

Defensive priority

Defenders should prioritize verifying and updating OpenEMR template systems, ensuring proper output encoding, and configuring HttpOnly cookie attributes to prevent session token exfiltration.

Recommended defensive actions

• Verify OpenEMR template systems for proper output encoding and HttpOnly cookie attributes
• Update OpenEMR to prevent session token exfiltration
• Monitor patient portal template system for suspicious activity
• Review compensating controls for exposed systems while remediation is scheduled and verified
• Check relevant monitoring, detection, and logs for exposed assets that need extra review
• Track exceptions, retest remediated assets, and close the item only after evidence is documented
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up

Evidence notes

The CVE record and NVD entry provide details on the vulnerability. Additional information on affected versions and remediation steps is limited. Defenders should verify OpenEMR template systems for proper output encoding and HttpOnly cookie attributes. They should also monitor patient portal template system for suspicious activity and review official advisories for specific guidance.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.